spacer
home > > autumn 2008 > electric avenue
PUBLICATIONS


Electric Avenue

THE BENEFITS OF ELECTRONIC DATA CAPTURE

The promise of information technology is being realised by businesses around the world. This is evidenced is in the way computing power allows tasks, and even entire processes, to be completed whilst providing the additional benefits of improved methodologies, higher speeds and lower costs. Now, stakeholders of electronic data capture (EDC) are looking to achieve similar benefits in their clinical trial processes earlier on, prior to deploying a finished solution. Some believe the answer lies in a more effective way of implementing EDC. They contend that the days of expensive technology transfer, long implementation times and resource-intensive processes are coming to an end.

As the pharmaceutical industry moves higher up the learning and experience curves for EDC, there is less debate about the need for, and benefits of, EDC solutions as a powerful and necessary component in the clinical trial landscape. The discussion has moved beyond the question of whether EDC is useful, because these web-based systems are allowing investigators to log their findings directly into a centralised database, delivering accurate data in near real-time. These data may then be analysed for such purposes as reviewing the progress of clinical trials, supporting trial adaptation and reducing the costs of providing statisticians with study information. EDC also helps improve efficiencies – a benefit of great interest in drug development.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Simon Hawken has more than 20 years’ experience of selling solutions into the biopharmaceutical sector. He currently serves as Director of Business Development for eResearchTechnology, Inc – the well-established cardiac safety leader also providing eClinical solutions – and is based in the UK. He holds a BA degree in Economics and has worked for IMS Health, IBM Corporation, Xerox and BEA Systems Inc, among others.
spacer
Simon Hawken
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Evolution Summit Press Release

“Many clinical trials today face delays because of difficulties in recruiting the required number of patients within the timeline. Sponsors need to look at other regions outside the US and Western Europe, that have access to a large pool of motivated patients, without compromising quality or anything else,” says Roman Hrynchuk, Chief Operating Officer, SanaClis. SanaClis was a solution provider at the Marcus Evans Evolution Summit March 2020.
More info >>

White Papers

Clinical Trials in Emerging Markets: Goldmines or Landmines?

Pharm-Olam, LLC

Over the past decade, biopharmaceutical companies have increasingly turned to emerging markets as a way to reduce clinical trial costs and timelines. Areas such as Eastern Europe, India, and Latin America—with their ready population of treatment naïve patients—can be an answer to the intense competition for patients seen in developed markets. Many of the countries within these regions may now be considered as “emerged” countries but yet, conducting trials in these regions does require some special attention and expertise. Before deciding to conduct studies in these areas, companies should have a full appreciation for the ethical, medical, regulatory, legal, and operational hurdles that must be surmounted for success. Here we highlight a number of those issues and offer our recommendations for how sponsor companies can deal with them effectively.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement